MARSHALL WACE, LLP - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q4 2022$1,853,280
-60.2%
37,125
-71.1%
0.00%
-55.6%
Q1 2022$4,662,000
-74.1%
128,290
-66.8%
0.01%
-72.7%
Q4 2021$18,032,000
+210.7%
386,873
+173.7%
0.03%
+26.9%
Q2 2021$5,803,000
+745.9%
141,375
+498.5%
0.03%
+766.7%
Q1 2021$686,000
+27.7%
23,622
+87.3%
0.00%
-25.0%
Q2 2020$537,00012,6140.00%
Other shareholders
LEGEND BIOTECH CORP shareholders Q1 2022
NameSharesValueWeighting ↓
FengHe Fund Management Pte. Ltd. 997,714$36,257,00013.28%
JOHNSON & JOHNSON 1,629,173$59,204,00011.19%
Paradigm Biocapital Advisors LP 831,728$30,225,0007.99%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,100,542$39,994,0005.54%
HHLR ADVISORS, LTD. 6,936,617$252,077,0005.26%
Old Well Partners, LLC 79,700$2,896,0001.94%
Parkman Healthcare Partners LLC 120,473$4,378,0001.28%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 4,500$5,632,0001.27%
AtonRa Partners 50,928$1,851,0001.00%
Avidity Partners Management LP 1,095,000$39,792,0000.83%
View complete list of LEGEND BIOTECH CORP shareholders